Advances of androgen receptor in triple-negative breast cancer: from molecular mechanisms to clinical applications
{{output}}
Triple-negative breast cancer (TNBC) is a clinically aggressive malignancy with high heterogeneity at molecular and genetic levels, which characterized by the absence of effective therapeutic targets and marked resistance to conventional chemotherapy regimens.... ...
